Report #2872628

Received Nov 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 66 yrs
State: CO
Recovered: Unknown
Vaccinated: Nov 10, 2025
Onset: Nov 10, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	1	EC2R9	—

Symptoms (1)

Expired product administered

Symptom narrative

mal administration of an expired dose of AREXVY; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 66-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number EC2R9, expiry date 03-NOV-2025) for prophylaxis. On 10-NOV-2025, the patient received the 1st dose of Arexvy. On 10-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: mal administration of an expired dose of AREXVY). The outcome of the expired vaccine used was not applicable. Additional Information: The reporter called to report the mal administration of an expired dose of Arexvy. The reporter called to know if revaccination was required. The Vaccine Administration Facility was the same as Primary Reporter.